- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 31.03. | Health Care Technology And Tactics For Addressing Gaps In Patient Communication | ||
| 31.03. | How Mass General Brigham Decides Which AI Tools Are Worth Scaling | ||
| 31.03. | State Mitigation Strategies Could Blunt Medicaid Coverage Losses | ||
| 30.03. | Kailera Plans IPO for Obesity Drug That Could Top Lilly's Zepbound | ||
| 30.03. | MedCity Pivot Podcast: How Fujifilm Tackled An Existential Crisis | ||
| 30.03. | Top-Paying Healthcare Settings for Travel Nurses and How to Land Them | ||
| 30.03. | AI Is Fueling a New Arms Race in Healthcare: Here's How We Stop It | ||
| 30.03. | Red Light Therapy's Regulatory Implications | ||
| 30.03. | Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment | ||
| 30.03. | Everlywell, Jona Team Up to Expand Access to Gut Microbiome Test | ||
| 29.03. | FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune Disorder | ||
| 29.03. | How Are Health Systems Assessing ROI for AI Tools? | ||
| 29.03. | Scaling Autonomous AI in Healthcare Without Compromising Clinical Trust | ||
| 29.03. | The Cost Blind Spot: Why Non-Clinical Spend Is Healthcare's Untapped Opportunity | ||
| 29.03. | AI Can Expand Access to Healthcare - But Only With Human Action | ||
| 27.03. | Taking a Page From Cancer Drugs, Autoimmune Biotech Alumis Aims for Precision Immunology | ||
| 27.03. | UnitedHealthcare Unveils AI Companion to Improve Navigation | ||
| 27.03. | DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian | ||
| 27.03. | How Real-World Data Is Reshaping the NSCLC Patient Journey | ||
| 27.03. | Closing Behavioral Care Gaps: Three Ways Providers And Health Plans Can Reimagine Care | ||
| 27.03. | Democratizing Access: How Community Hospitals Can Drive the Next Wave of Robotic Bronchoscopy | ||
| 27.03. | Top Companies to Build and Operate Mobile Clinics for Your Organization | ||
| 27.03. | 'This is Crazy': Health Experts Call for Changes to the No Surprises Act | ||
| 26.03. | FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating Drugs | ||
| 26.03. | Why Agentic AI is Useful But Limited & Other Hot Takes on the AI Market |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.